At what cost is collagenase clostridium histolyticum viable for treating Peyronie's disease in a public healthcare system?

Harvey, Neil; Pearce, Ian

Harvey, Neil; Pearce, Ian.

Affiliation

Harvey N; Urology Department, Stepping Hill Hospital, Stockport NHS Foundation Trust, Poplar Grove, UK.
Pearce I; Urology Department, Manchester Royal Infirmary, Manchester University Hospitals Foundation Trust, Manchester, UK.

Andrology ; 8(5): 1304-1311, 2020 09.

Article in En | MEDLINE | ID: mdl-32459883

Subject(s)

Microbial Collagenase/economics; Microbial Collagenase/therapeutic use; Penile Induration/therapy; Cost-Benefit Analysis; Humans; Male; State Medicine/economics; Treatment Outcome; United Kingdom; Urologic Surgical Procedures, Male/economics

Key words

Xiaflex; Xiapex

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Penile Induration / Microbial Collagenase Type of study: Health_economic_evaluation Limits: Humans / Male Country/Region as subject: Europa Language: En Journal: Andrology Year: 2020 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google